Second Sight to Discuss 2015 Second Quarter Financial Results on August 4, 2015 Conference Call
SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2015 second quarter results on Tuesday, August 4, 2015, after the close of the U.S. financial markets.
Dr. Robert Greenberg, President and Chief Executive Officer, and Tom Miller, Chief Financial Officer, will host a conference call to discuss the results as follows:
Date | Tuesday, August 4, 2015 | |
Time | 4:30 p.m. EDT | |
Toll free (U.S.) | 800-754-1366 | |
International |
212-231-2928 |
|
Webcast (live and replay) |
www.secondsight.com under the ‘Investor Relations’ section. |
A replay of the conference call will be available for two weeks after the call's completion by dialing (800) 633-8284 (U.S.) or (402) 977-9140 (International). The conference ID for the replay is 21772680. The archived webcast will be available for 30 days via the aforementioned URL.
About Second Sight
Second Sight's mission is to develop,
manufacture and market innovative implantable visual prosthetics to
enable blind individuals to achieve greater independence. Second Sight
has developed and manufactures the Argus® II Retinal Prosthesis System.
Enrollment is underway in a trial to test the safety and utility of the
Argus II in individuals with Dry Age-Related Macular Degeneration.
Second Sight is also developing the Orion™ I Visual Cortical Prosthesis
to restore some vision to individuals who are blind due to causes other
than preventable or treatable conditions. U.S. Headquarters are
in Sylmar, CA, and European Headquarters are in Lausanne, Switzerland.
For more information, visit www.secondsight.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150727005422/en/
Investor Relations:
Retail Investors:
MZ North America
Matt
Hayden, 949-259-4896
Chairman
matt.hayden@mzgroup.us
or
Institutional
Investors:
In-Site Communications, Inc.
Lisa Wilson,
212-452-2793
President
lwilson@insitecony.com
Source: Second Sight Medical Products, Inc.
Released July 27, 2015